Quarterly Updates15 May 2026, 03:19 pm
Ind-Swift Labs: Monitoring Agency Report for March 2026
AI Summary
Ind-Swift Laboratories Ltd has released the Monitoring Agency Report by CARE Ratings Limited for the quarter ended March 31, 2026, regarding the utilization of proceeds from a preferential issue of ₹314.60 crore. The report indicates no deviations from the stated objectives of the issue. The Audit Committee and the Board have reviewed and taken the report on record, as per SEBI regulations.
Key Highlights
- CARE Ratings monitored the utilization of ₹314.60 crore from the preferential issue.
- The report confirms no deviation from the stated objectives of the issue.
- The report was reviewed by the Audit Committee and Board of Directors.
- The monitoring is in accordance with SEBI regulations.
- CARE Ratings declares no conflict of interest in monitoring the issue proceeds.
Price Impact
More from INDSWFTLAB